We are monitoring the impact of COVID-19 on North America Antacid Market Get in touch with us for detailed analysis Know More
Share on

North America Antacid Market Research Report – Segmented By Drug Class, Formulation Type, Distribution Channel & Country (The United States, Canada & Rest of North America) – Industry Size, Share, Trends & Growth Forecasts (2022 to 2027)

Published: January, 2022
ID: 2266
Pages: 145

North America Antacid Market Size & Growth (2022 to 2027):

The size of the North American Antacid Market is valued at USD 5.15 billion in 2022, and it is predicted to be growing at a CAGR of 4.6% and value USD 6.44 billion by 2027 during the forecast period.

The rising prevalence of Gastroesophageal Reflux Diseases (GERD) is expected to impact the overall market over the forecast period. Furthermore, rising GERD awareness is expected to enhance the antacids industry. Therefore, dietary change is one of the primary elements likely to promote development during the projection period.

Heartburn's rising prevalence is also expected to impact the market over the forecast period. In addition, the availability of chewable tablets in various tastes aids patient adherence to medication, which is projected to contribute to market expansion.

The rise of the antacid market in North America is primarily due to the rising prevalence of GERD and obesity. However, in low-income countries, a lack of understanding about gastrointestinal problems limits the Antacid market's growth.

Changing eating choices, a growing senior population around the world, a sedentary lifestyle, and an increase in gastroesophageal reflux disease are all factors driving the expansion of the North American antacid market.

Furthermore, the rising consumption of foods such as fried or fatty foods, citrus, chocolate, coffee, carbonated beverages, and other items that increase gastric HCl content in the stomach leads to antacid adoption, enhancing the market for antacids in North America.

Companies are reorganizing their operations and recovering from the pandemic, which had previously resulted in tight containment measures like social distancing, remote working, and the termination of commercial activities, making operations difficult and risky.

Antacid side effects are a significant stumbling block for the antacids market. Dose-dependent rebound hyperacidity and milk-alkali syndrome are two common antacid adverse effects.

However, the expanding number of antacid alternatives on the market and people's ignorance of acidity symptoms are likely to harm market growth.

This research report on the North American antacid market has been segmented and sub-segmented into the following categories.

By Drug Class: 

  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
  • Pro-motility Agents

By Formulation Type: 

  • Tablet
  • Liquid
  • Powder

By Distribution Channel: 

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Country: 

  • The United States
  • Canada
  • Rest of North America

Geographically, North America is predicted to be the most significant and fastest-growing regional market to rise as healthcare infrastructure improves and market actors raise their investments.

The U.S Antacid Market is predicted to rise rapidly due to the expanding geriatric population and lifestyle changes leading to gastrointestinal disorders among the American people. In addition, the growing trend toward self-medication is driving up demand for over-the-counter digestive products like antacids.

Antacids are the most commonly purchased OTC medications in the United States. This was ascribed to a rise in the occurrence of digestive disorders and increased consumer knowledge of antacid products.

The Canada Antacid Market is expected to reach significant growth during the period due to developed economies contributing to the development in the region.

The demand for antacids is driven by poor lifestyle choices resulting in a higher prevalence of acidity. Poor lifestyle choices include desk work, poor sleep quality, and irregular food habits, all of which cause a rise in stomach acidity and lead to gastroesophageal reflux disease. This fuels the market for antacids in the region.

KEY MARKET PLAYERS

Some of the leading companies in the North American antacid market profiled in the report are GlaxoSmithKline plc, Abbott Laboratories, Pfizer, Inc., Sun Pharma, Digene, Pudin Hara (Dabur), and Gelusil (Pfizer).,

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Drug Class               

                                5.1.1 Introduction     

                                5.1.2 Proton Pump Inhibitors

                                5.1.3 H2 Antagonist

                                5.1.4 Acid Neutralizers

                                5.1.5 Pro-motility Agents      

                                5.1.6 Y-o-Y Growth Analysis, By Drug Class    

                                5.1.7 Market Attractiveness Analysis, By Drug Class  

                                5.1.8 Market Share Analysis, By Drug Class   

                5.2 Formulation Type                 

                                5.2.1 Introduction           

                                5.2.2 Tablet

                                5.2.3 Liquid

                                5.2.4 Powder           

                                5.2.5 Y-o-Y Growth Analysis, By Formulation Type     

                                5.2.6 Market Attractiveness Analysis, By Formulation Type      

                                5.2.7 Market Share Analysis, By Formulation Type      

                5.3 Distribution Channels         

                                5.3.1 Introduction           

                                5.3.2 Hospital Pharmacies 

                                5.3.3 Retail Pharmacies    

                                5.3.4 Others    

                                5.3.5 Y-o-Y Growth Analysis, By Distribution Channel       

                                5.3.6 Market Attractiveness Analysis, By Distribution Channel  

                                5.3.7 Market Share Analysis, By Distribution Channel

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Drug Class

                                                6.1.3.3 By Formulation Type

                                                6.1.3.5 By Distribution Channel

                                6.1.4 Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Drug Class

                                                6.1.4.3 By Formulation Type

                                                6.1.4.4 By Distribution Channel

                                6.1.5 Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Drug Class

                                                6.1.5.3 By Formulation Type

                                                6.1.5.4 By Distribution Channel

                6.2 United States                            

                6.3 Canada                         

7. Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 First Aid Only                             

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GSK                

                8.3 Abbott

                8.4 Pfizer, Inc

                8.5 Sun Pharma

                8.6 Digene

                8.7 Pudin Hara (Dabur)

9. Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Antacid Market, By Drug Class, From 2022 to 2027 (USD Million)
  2. North America Proton Pump Inhibitors Market, By Region, From 2022 to 2027 (USD Million)
  3. North America H2 Antagonist Market, By Region, From 2022 to 2027 (USD Million)
  4. North America Acid Neutralizers Market, By Region, From 2022 to 2027 (USD Million)
  5. North America Pro-Motility Agents Market, By Region, From 2022 to 2027 (USD Million)
  6. North America Antacid Market, By Formulation type, From 2022 to 2027 (USD Million)
  7. North America Tablet Market, By Region, From 2022 to 2027 (USD Million)
  8. North America Liquid Market, By Region, From 2022 to 2027 (USD Million)
  9. North America Powder Market, By Region, From 2022 to 2027 (USD Million)
  10. North America Antacid Market, By Distribution Channel, From 2022 to 2027 (USD Million)
  11. North America Hospital Pharmacies Market, By Region, From 2022 to 2027 (USD Million)
  12. North America Retail Pharmacies Market, By Region, From 2022 to 2027 (USD Million)
  13. North America Others Market, By Region, From 2022 to 2027 (USD Million)
  14. United States Antacid Market, By Drug Class, From 2022 to 2027 (USD Million)
  15. United States Antacid Market, By Formulation type, From 2022 to 2027 (USD Million)
  16. United States Antacid Market, By Distribution Channel, From 2022 to 2027 (USD Million)
  17. Canada Antacid Market, By Drug Class, From 2022 to 2027 (USD Million)
  18. Canada Antacid Market, By Formulation type, From 2022 to 2027 (USD Million)
  19. Canada Antacid Market, By Distribution Channel, From 2022 to 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample